EMA Issues Advice on Regeneron's Antibody Cocktail (casirivimab with imdevimab) for Certain COVID-19 Patients

Go back to EMA Issues Advice on Regeneron's Antibody Cocktail (casirivimab with imdevimab) for Certain COVID-19 Patients
Regeneron (NASDAQ: REGN) Delayed: 827.72 --0 (-0%)
Previous Close $827.72    52 Week High $592.36 
Open $827.72    52 Week Low $325.35 
Day High $827.72    P/E 217.25 
Day Low $827.72    EPS $3.81 
Volume 100